Related Experiment Video
Updated: Aug 6, 2026
07:31
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Implementation of a Statewide Prescription Drug Monitoring Program - Healthcare Practitioners' Perspectives
Emma Tay1,2, Meredith Makeham1, Melissa Baysari1
1The University of Sydney, Sydney, Australia.
Studies in Health Technology and Informatics
|July 16, 2026
Summary
Healthcare practitioners reported challenges with SafeScript NSW awareness and uptake. Improving promotion and addressing barriers are key for optimizing prescription drug monitoring programs (PDMPs).
Area of Science:
- Public Health
- Health Services Research
- Pharmacovigilance
Background:
- Prescription drug monitoring programs (PDMPs) are crucial for managing high-risk medication use and associated harms.
- SafeScript NSW is New South Wales's implementation of a statewide PDMP.
Purpose of the Study:
- To explore healthcare practitioners' perspectives on the implementation of SafeScript NSW.
- To identify facilitators and barriers to the effective use of PDMPs.
Main Methods:
- A mixed-methods evaluation incorporating semi-structured interviews.
- Interviews were conducted with 14 prescribers (GPs, specialists, NPs) and pharmacists impacted by SafeScript NSW.
Main Results:
- Participants identified successful implementation strategies but noted poor awareness among some key medical specialties.
- Barriers to long-term success and facilitators were identified.
- Perceptions regarding mandatory PDMP use were mixed.
Conclusions:
- End-user insights are vital for enhancing PDMP awareness and adoption.
- Optimizing PDMP implementation requires targeted promotional efforts and addressing identified end-user concerns.
- Strategies informed by healthcare practitioners can improve the realization of PDMP benefits.
Related Concept Videos
01:17Healthcare Agencies II
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...